Oric Pharmaceuticals, Inc. ORIC Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $31.44M+21.6% | $25.86M-10.1% | $28.77M-5.8% | $30.55M+24.0% | $24.64M-22.9% | ||
| $8.18M-5.9% | $8.7M+10.1% | $7.9M-7.2% | $8.52M+5.4% | $8.08M+6.3% | ||
| $39.62M+14.7% | $34.55M-5.8% | $36.67M-6.1% | $39.06M+19.4% | $32.72M-17.3% | ||
| -$39.62M-14.7% | -$34.55M+5.8% | -$36.67M+6.1% | -$39.06M-19.4% | -$32.72M+17.3% | ||
| $3.85M-4.8% | $4.05M-0.9% | $4.08M+50.8% | $2.71M+0.4% | $2.7M-17.3% | ||
| -$35.77M-17.2% | -$30.51M+6.4% | -$32.59M+10.4% | -$36.36M-21.1% | -$30.02M+17.3% | ||
| -$0.34-25.9% | -$0.27+18.2% | -$0.33+29.8% | -$0.47-11.9% | -$0.42+17.6% | ||
| -$39.35M-15.0% | -$34.23M+5.9% | -$36.38M+6.1% | -$38.75M-19.6% | -$32.42M+17.4% | ||
| -$39.62M-14.7% | -$34.55M+5.8% | -$36.67M+6.1% | -$39.06M-19.4% | -$32.72M+17.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Oric Pharmaceuticals, Inc. profitable?
- Oric Pharmaceuticals, Inc. is not currently profitable: it reported a net loss of $135.2M over the trailing twelve months.
- What is Oric Pharmaceuticals, Inc.'s earnings per share?
- Oric Pharmaceuticals, Inc.'s diluted EPS over the trailing twelve months is $-1.41.
- Where does Oric Pharmaceuticals, Inc.'s income statement data come from?
- Every line is extracted from Oric Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.